Impact of Diabetes Duration on Major Adverse Cardiac Events in Patients with Non-Obstructive Coronary Artery Disease

Yun-Ah Lee1, Sang-Wook Song1, Se-Hong Kim1

  • 1Department of Family Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul 16247, Republic of Korea.

PubMed

Insights

Longer diabetes duration significantly increases cardiovascular risks in patients with non-obstructive coronary artery disease (CAD). Even mild CAD combined with over 10 years of diabetes elevates major adverse cardiovascular and cerebrovascular events (MACCEs) and mortality.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Diabetes mellitus is a significant risk factor for coronary artery disease (CAD).
  • Diabetes duration is associated with adverse clinical outcomes in CAD patients.
  • Understanding these risks in non-obstructive CAD is crucial for patient management.

Purpose of the Study:

  • To evaluate the impact of diabetes duration on major adverse cardiovascular and cerebrovascular outcomes (MACCEs) and mortality.
  • To assess risks specifically in Korean patients with non-obstructive CAD.
  • To identify diabetes duration as a potential predictor for outcomes in this population.

Main Methods:

  • Retrospective, single-center study using medical records of 4287 patients undergoing coronary angiography (2010-2015).
  • Identified 517 patients with non-obstructive CAD (20-49% stenosis).
  • Categorized patients into: no diabetes, diabetes <10 years, and diabetes ≥10 years.

Main Results:

  • Patients with non-obstructive CAD and diabetes ≥10 years had a nearly fourfold increased risk of MACCEs (aHR 4.61) compared to non-diabetic patients.
  • Significantly higher risks of cardiovascular death (aHR 12.42) and non-fatal stroke (aHR 4.97) were observed in the diabetes ≥10 years group.
  • These risks remained significant after adjusting for covariates over a median 60-month follow-up.

Conclusions:

  • Longer diabetes duration is associated with increased MACCEs in patients with non-obstructive CAD.
  • Diabetes duration is a critical factor for predicting mortality in this patient group.
  • Clinical attention to diabetes duration may improve risk stratification for non-obstructive CAD patients.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
475
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
207
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.5K